Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

VU0453595

Copy Product Info
🥰Excellent
Catalog No. T29137Cas No. 1432436-13-9
Alias VU-0453595, VU 0453595

VU0453595 is a M1 positive allosteric modulator (PAM).

VU0453595

VU0453595

Copy Product Info
🥰Excellent
Purity: 99.91%
Catalog No. T29137Alias VU-0453595, VU 0453595Cas No. 1432436-13-9
VU0453595 is a M1 positive allosteric modulator (PAM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$38In StockIn Stock
5 mg$58In StockIn Stock
10 mg$98In StockIn Stock
25 mg$191In StockIn Stock
50 mg$296In StockIn Stock
1 mL x 10 mM (in DMSO)$58In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.91%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

VU0453595 AI Summary
VU0453595 exhibits positive allosteric modulation at both rat and human muscarinic acetylcholine receptor M1, enhancing acetylcholine-induced calcium mobilization with EC50 values of 3200.0 nM and 1900.0 nM for rat and human receptors, respectively. Additionally, it affects beta-arrestin recruitment at the human receptor with an EC50 value of 2600.0 nM. The compound shows selectivity towards the rat receptor with a selectivity ratio of 3.0. In Sprague-Dawley rats, the brain-to-plasma partition coefficient is Kp = 0.3 following intravenous administration..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
VU0453595 is a M1 positive allosteric modulator (PAM).
SynonymsVU-0453595, VU 0453595
Chemical Properties
Molecular Weight322.34
FormulaC18H15FN4O
Cas No.1432436-13-9
SmilesCn1cc(cn1)-c1ccc(CN2Cc3ncccc3C2=O)c(F)c1
Relative Density.1.35 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (310.23 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (12.41 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1023 mL15.5116 mL31.0231 mL155.1157 mL
5 mM0.6205 mL3.1023 mL6.2046 mL31.0231 mL
10 mM0.3102 mL1.5512 mL3.1023 mL15.5116 mL
20 mM0.1551 mL0.7756 mL1.5512 mL7.7558 mL
50 mM0.0620 mL0.3102 mL0.6205 mL3.1023 mL
100 mM0.0310 mL0.1551 mL0.3102 mL1.5512 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy VU0453595 | purchase VU0453595 | VU0453595 cost | order VU0453595 | VU0453595 chemical structure | VU0453595 formula | VU0453595 molecular weight